Alpha-Actinin 4 and Tumorigenesis of Breast Cancer

Vitamins and Hormones

Volumn 93, Issue , 2013, Pages 323-351

  Hsu, Kuo Sheng ^a   Kao, Hung Ying ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha actinin 4; Breast cancer; Cytoskeleton; Nuclear receptor; Tumorigenesis

Indexed keywords

EID: 84880262331     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-416673-8.00005-8     Document Type: Chapter

References (109)

1. Agarwal N., Adhikari A.S., Iyer S.V., Hekmatdoost K., Welch D.R., Iwakuma T. MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4. Oncogene 2013, 32:462-470.
2. Ahmed K.M., Cao N., Li J.J. HER-2 and NF-κB as the targets for therapy-resistant breast cancer. Anticancer Research 2006, 26:4235-4243.
3. Araki N., Hatae T., Yamada T., Hirohashi S. Actinin-4 is preferentially involved in circular ruffling and macropinocytosis in mouse macrophages: Analysis by fluorescence ratio imaging. Journal of Cell Science 2000, 113:3329-3340.
4. Are A.F., Galkin V.E., Pospelova T.V., Pinaev G.P. The p65/RelA subunit of NF-kappaB interacts with actin-containing structures. Experimental Cell Research 2000, 256:533-544.
5. Arimura C., Suzuki T., Yanagisawa M., Imamura M., Hamada Y., Masaki T. Primary structure of chicken skeletal muscle and fibroblast alpha-actinins deduced from cDNA sequences. European Journal of Biochemistry 1988, 177:649-655.
6. Atkinson R.A., Joseph C., Kelly G., Muskett F.W., Frenkiel T.A., Nietlispach D., et al. Ca2+-independent binding of an EF-hand domain to a novel motif in the alpha-actinin-titin complex. Nature Structural Biology 2001, 8:853-857.
7. Babakov V.N., Petukhova O.A., Turoverova L.V., Kropacheva I.V., Tentler D.G., Bolshakova A.V., et al. RelA/NF-κB transcription factor associates with α-actinin-4. Experimental Cell Research 2008, 314:1030-1038.
8. Barbolina M.V., Adley B.P., Kelly D.L., Fought A.J., Scholtens D.M., Shea L.D., et al. Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma. Laboratory Investigation 2008, 88:602-614.
9. Beggs A.H., Byers T.J., Knoll J.H., Boyce F.M., Bruns G.A., Kunkel L.M. Cloning and characterization of two human skeletal muscle alpha-actinin genes located on chromosomes 1 and 11. Journal of Biological Chemistry 1992, 267:9281-9288.
10. Biswas D.K., Shi Q., Baily S., Strickland I., Ghosh S., Pardee A.B., et al. NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:10137-10142.
11. Bolshakova A., Petukhova O., Turoverova L., Tentler D., Babakov V., Magnusson K.-E., et al. Extra-cellular matrix proteins induce re-distribution of alpha-actinin-1 and alpha-actinin-4 in A431 cells. Cell Biology International 2007, 31:360-365.
12. Brenton J.D., Carey L.A., Ahmed A.A., Caldas C. Molecular classification and molecular forecasting of breast cancer: Ready for clinical application?. Journal of Cell Oncology 2005, 23:7350-7360.
13. Carragher N.O., Fincham V.J., Riley D., Frame M.C. Cleavage of focal adhesion kinase by different proteases during src-regulated transformation and apoptosis. Distinct roles for calpain and caspases. Journal of Biological Chemistry 2001, 276:4270-4275.
14. FAK, Paxillin, and Talin. The Journal of Cell Biology 1999, 147:619-630.
15. Castaneda C., Cortes-Funes H., Gomez H., Ciruelos E. The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer. Cancer and Metastasis Reviews 2010, 29:751-759.
16. Chakraborty S., Reineke E.L., Lam M., Li X., Liu Y., Gao C., et al. α-Actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase 7. Journal of Biological Chemistry 2006, 281:35070-35080.
17. Christerson L.B., Vanderbilt C.A., Cobb M.H. MEKK1 interacts with α-actinin and localizes to stress fibers and focal adhesions. Cell Motility and the Cytoskeleton 1999, 43:186-198.
18. Cuevas B.D., Abell A.N., Witowsky J.A., Yujiri T., Johnson N.L., Kesavan K., et al. MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO Journal 2003, 22:3346-3355.
19. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
20. Ding Z., Liang J., Lu Y., Yu Q., Songyang Z., Lin S.-Y., et al. A retrovirus-based protein complementation assay screen reveals functional AKT1-binding partners. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:15014-15019.
21. Djinovic-Carugo K., Gautel M., Ylänne J., Young P. The spectrin repeat: A structural platform for cytoskeletal protein assemblies. FEBS Letters 2002, 513:119-123.
22. Djinović-Carugo K., Young P., Gautel M., Saraste M. Structure of the alpha-actinin rod: Molecular basis for cross-linking of actin filaments. Cell 1999, 98:537-546.
23. Dourdin N., Bhatt A.K., Dutt P., Greer P.A., Arthur J.S.C., Elce J.S., et al. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. Journal of Biological Chemistry 2001, 276:48382-48388.
24. Downey C., Craig D.H., Basson M.D. Isoform-specific modulation of pressure-stimulated cancer cell proliferation and adhesion by α-actinin. American Journal of Surgery 2011, 202:520-523.
25. Dressel U., Bailey P.J., Wang S.-C.M., Downes M., Evans R.M., Muscat G.E.O. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. Journal of Biological Chemistry 2001, 276:17007-17013.
26. Edlund M., Lotano M.A., Otey C.A. Dynamics of α-actinin in focal adhesions and stress fibers visualized with α-actinin-green fluorescent protein. Cell Motility and the Cytoskeleton 2001, 48:190-200.
27. Fellenberg J., Dechant M.J., Ewerbeck V., Mau H. Identification of drug-regulated genes in osteosarcoma cells. International Journal of Cancer 2003, 105:636-643.
28. Fraley T.S., Pereira C.B., Tran T.C., Singleton C., Greenwood J.A. Phosphoinositide binding regulates α-actinin dynamics. Mechanism for modulating cytoskeletal remodeling. Journal of Biological Chemistry 2005, 280:15479-15482.
29. Franzot G., Sjöblom B., Gautel M., Djinović Carugo K. The crystal structure of the actin binding domain from alpha-actinin in its closed conformation: Structural insight into phospholipid regulation of alpha-actinin. Journal of Molecular Biology 2005, 348:151-165.
30. Fu L., Qin Y.R., Xie D., Chow H.Y., Ngai S.M., Kwong D.L.W., et al. Identification of alpha-actinin 4 and 67kDa laminin receptor as stage-specific markers in esophageal cancer via proteomic approaches. Cancer 2007, 110:2672-2681.
31. Fukami K., Sawada N., Endo T., Takenawa T. Identification of a phosphatidylinositol 4,5-bisphosphate-binding site in chicken skeletal muscle α-actinin. Journal of Biological Chemistry 1996, 271:2646-2650.
32. Fyrberg E., Kelly M., Ball E., Fyrberg C., Reedy M.C. Molecular genetics of Drosophila alpha-actinin: Mutant alleles disrupt Z disc integrity and muscle insertions. The Journal of Cell Biology 1990, 110:1999-2011.
33. Greenwood J.A., Theibert A.B., Prestwich G.D., Murphy-Ullrich J.E. Restructuring of focal adhesion plaques by Pi 3-kinase regulation by PtdIns (3,4,5-P)3 binding to α-actinin. The Journal of Cell Biology 2000, 150:627-642.
34. Guo G., Yan-Sanders Y., Lyn-Cook B.D., Wang T., Tamae D., Ogi J., et al. Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Molecular and Cellular Biology 2003, 23:2362-2378.
35. Guvakova M.A., Adams J.C., Boettiger D. Functional role of α-actinin, PI 3-kinase and MEK1/2 in insulin-like growth factor I receptor kinase regulated motility of human breast carcinoma cells. Journal of Cell Science 2002, 115:4149-4165.
36. Hara T., Honda K., Shitashige M., Ono M., Matsuyama H., Naito K., et al. Mass spectrometry analysis of the native protein complex containing actinin-4 in prostate cancer cells. Molecular & Cellular Proteomics 2007, 6:479-491.
37. Hatakeyama H., Kondo T., Fujii K., Nakanishi Y., Kato H., Fukuda S., et al. Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 2006, 6:6300-6316.
38. Hayashida Y., Honda K., Idogawa M., Ino Y., Ono M., Tsuchida A., et al. E-Cadherin regulates the association between β-Catenin and Actinin-4. Cancer Research 2005, 65:8836-8845.
39. He J., Whelan S.A., Lu M., Shen D., Chung D.U., Saxton R.E., et al. Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response. International Journal of Proteomics 2011, 2011:1-16.
40. Henry W.I., Dubois J., Quick Q.A. The microtubule inhibiting agent epothilone B antagonizes glioma cell motility associated with reorganization of the actin-binding protein α-actinin 4. Oncology Reports 2011, 25:887-893.
41. Honda K., Yamada T., Endo R., Ino Y., Gotoh M., Tsuda H., et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. The Journal of Cell Biology 1998, 140:1383-1393.
42. Honda K., Yamada T., Seike M., Hayashida Y., Idogawa M., Kondo T., et al. Alternative splice variant of actinin-4 in small cell lung cancer. Oncogene 2004, 23:5257-5262.
43. Honda K., Yamada T., Hayashida Y., Idogawa M., Sato S., Hasegawa F., et al. Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 2005, 128:51-62.
44. Imamura M., Sakurai T., Ogawa Y., Ishikawa T., Goto K., Masaki T. Molecular cloning of low-Ca(2+)-sensitive-type non-muscle alpha-actinin. European Journal of Biochemistry 1994, 223:395-401.
45. Izaguirre G., Aguirre L., Hu Y.-P., Lee H.Y., Schlaepfer D.D., Aneskievich B.J., et al. The cytoskeletal/non-muscle isoform of α-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase. Journal of Biological Chemistry 2001, 276:28676-28685.
46. Jasavala R., Martinez H., Thumar J., Andaya A., Gingras A.-C., Eng J.K., et al. Identification of putative androgen receptor interaction protein modules cytoskeleton and endosomes modulate androgen receptor signaling in prostate cancer cells. Molecular & Cellular Proteomics 2007, 6:252-271.
47. Kao J., Salari K., Bocanegra M., Choi Y.-L., Girard L., Gandhi J., et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS One 2009, 4:e6146.
48. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annual Review of Immunology 2000, 18:621-663.
49. Khurana S., Chakraborty S., Cheng X., Su Y.-T., Kao H.-Y. The actin-binding protein, actinin alpha 4 (ACTN4), is a nuclear receptor coactivator that promotes proliferation of MCF-7 breast cancer cells. Journal of Biological Chemistry 2011, 286:1850-1859.
50. Khurana S., Chakraborty S., Lam M., Liu Y., Su Y.-T., Zhao X., et al. Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors. Journal of Biological Chemistry 2012, 287:12027-12035.
51. Kikuchi S., Honda K., Tsuda H., Hiraoka N., Imoto I., Kosuge T., et al. Expression and gene amplification of actinin-4 in invasive ductal carcinoma of the pancreas. Clinical Cancer Research 2008, 14:5348-5356.
52. Knudsen K.A., Soler A.P., Johnson K.R., Wheelock M.J. Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. The Journal of Cell Biology 1995, 130:67-77.
53. Knuefermann C., Lu Y., Liu B., Jin W., Liang K., Wu L., et al. HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene 2003, 22:3205-3212.
54. Kobayashi R., Kamiie J., Yasuno K., Ogihara K., Shirota K. Expression of nephrin, podocin, α-actinin-4 and α3-integrin in canine renal glomeruli. Journal of Comparative Pathology 2011, 145:220-225.
55. Koizumi T., Nakatsuji H., Fukawa T., Avirmed S., Fukumori T., Takahashi M., et al. The role of actinin-4 in bladder cancer invasion. Urology 2010, 75:357-364.
56. Kumeta M., Yoshimura S.H., Harata M., Takeyasu K. Molecular mechanisms underlying nucleocytoplasmic shuttling of actinin-4. Journal of Cell Science 2010, 123:1020-1030.
57. Kusunoki H., MacDonald R.I., Mondragón A. Structural insights into the stability and flexibility of unusual erythroid spectrin repeats. Structure 2004, 12:645-656.
58. Laukaitis C.M., Webb D.J., Donais K., Horwitz A.F. Differential dynamics of α5 integrin, paxillin, and α-actinin during formation and disassembly of adhesions in migrating cells. The Journal of Cell Biology 2001, 153:1427-1440.
59. Liang K., Jin W., Knuefermann C., Schmidt M., Mills G.B., Ang K.K., et al. Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy1. Molecular Cancer Therapeutics 2003, 2:353-360.
60. Liu H., Lee E.-S., Gajdos C., Pearce S.T., Chen B., Osipo C., et al. Apoptotic action of 17β-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo. Journal of the National Cancer Institute 2003, 95:1586-1597.
61. Luo J., Manning B.D., Cantley L.C. Targeting the PI3K-Akt pathway in human cancer: Rationale and promise. Cancer Cell 2003, 4:257-262.
62. Maruyama K., Ebashi S. α-Actinin, a new structural protein from striated muscle II. Action on actin. Journal of Biochemistry 1965, 58:13-19.
63. Masaki T., Endo M., Ebashi S. Localization of 6S component of a alpha-actinin at Z-band. Journal of Biochemistry 1967, 62:630-632.
64. Mazzocca A., Liotta F., Carloni V. Tetraspanin CD81-regulated cell motility plays a critical role in intrahepatic metastasis of hepatocellular carcinoma. Gastroenterology 2008, 135:244-256. e1.
65. Menez J., Chansac B.L.M., Dorothée G., Vergnon I., Jalil A., Carlier M.-F., et al. Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinoma. Oncogene 2004, 23:2630-2639.
66. Mills M., Yang N., Weinberger R., Woude D.L.V., Beggs A.H., Easteal S., et al. Differential expression of the actin-binding proteins, α-actinin-2 and -3, in different species: Implications for the evolution of functional redundancy. Human Molecular Genetics 2001, 10:1335-1346.
67. Nakshatri H., Bhat-Nakshatri P., Martin D.A., Goulet R.J., Sledge G.W. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Molecular and Cellular Biology 1997, 17:3629-3639.
68. Nikolopoulos S.N., Spengler B.A., Kisselbach K., Evans A.E., Biedler J.L., Ross R.A. The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells. Oncogene 2000, 19:380-386.
69. Oikonomou K.G., Zachou K., Dalekos G.N. Alpha-actinin: A multidisciplinary protein with important role in B-cell driven autoimmunity. Autoimmunity Reviews 2011, 10:389-396.
70. Osborne C.K., Schiff R. Mechanisms of endocrine resistance in breast cancer. Annual Review of Medicine 2011, 62:233-247.
71. Otey C.A., Carpen O. α-Actinin revisited: A fresh look at an old player. Cell Motility and the Cytoskeleton 2004, 58:104-111.
72. Otey C.A., Pavalko F.M., Burridge K. An interaction between alpha-actinin and the beta 1 integrin subunit in vitro. The Journal of Cell Biology 1990, 111:721-729.
73. Pan S., Chen R., Reimel B.A., Crispin D.A., Mirzaei H., Cooke K., et al. Quantitative proteomics investigation of pancreatic intraepithelial neoplasia. Electrophoresis 2009, 30:1132-1144.
74. Pavalko F.M., Burridge K. Disruption of the actin cytoskeleton after microinjection of proteolytic fragments of alpha-actinin. The Journal of Cell Biology 1991, 114:481-491.
75. Pavalko F.M., Otey C.A., Simon K.O., Burridge K. Alpha-actinin: A direct link between actin and integrins. Biochemical Society Transactions 1991, 19:1065-1069.
76. Pavalko F.M., Walker D.M., Graham L., Goheen M., Doerschuk C.M., Kansas G.S. The cytoplasmic domain of L-selectin interacts with cytoskeletal proteins via alpha-actinin: Receptor positioning in microvilli does not require interaction with alpha-actinin. The Journal of Cell Biology 1995, 129:1155-1164.
77. Perou C.M., Sørlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., et al. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
78. Pianetti S., Arsura M., Romieu-Mourez R., Coffey R.J., Sonenshein G.E. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 2001, 20:1287-1299.
79. Piva R., Belardo G., Santoro M.G. NF-kappaB: A stress-regulated switch for cell survival. Antioxidants & Redox Signaling 2006, 8:478-486.
80. Pohlmann P.R., Mayer I.A., Mernaugh R. Resistance to trastuzumab in breast cancer. Clinical Cancer Research 2009, 15:7479-7491.
81. Pratt M.A.C., Bishop T.E., White D., Yasvinski G., Ménard M., Niu M.Y., et al. Estrogen withdrawal-induced NF-κB activity and Bcl-3 expression in breast cancer cells: Roles in growth and hormone independence. Molecular and Cellular Biology 2003, 23:6887-6900.
82. Quick Q., Skalli O. α-Actinin 1 and α-actinin 4: Contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells. Experimental Cell Research 2010, 316:1137-1147.
83. Rosette C., Karin M. Cytoskeletal control of gene expression: Depolymerization of microtubules activates NF-kappa B. The Journal of Cell Biology 1995, 128:1111-1119.
84. Sarrió D., Rodriguez-Pinilla S.M., Hardisson D., Cano A., Moreno-Bueno G., Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Research 2008, 68:989-997.
85. Sen S., Dong M., Kumar S. Isoform-Specific Contributions of α-Actinin to Glioma Cell Mechanobiology. PLoS One 2009, 4:e8427.
86. Shao H., Wang J.H., Pollak M.R., Wells A. α-Actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. PLoS One 2010, 5:e13921.
87. Shao H., Wu C., Wells A. Phosphorylation of α-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin. Journal of Biological Chemistry 2010, 285:2591-2600.
88. Sheterline P., Clayton J., Sparrow J. Actin. Protein Profile 1995, 2:1-103.
89. Shibasaki F., Fukami K., Fukui Y., Takenawa T. Phosphatidylinositol 3-kinase binds to alpha-actinin through the p85 subunit. Biochemical Journal 1994, 302:551-557.
90. Shih I.-M., Kurman R.J. Ovarian tumorigenesis: A proposed model based on morphological and molecular genetic analysis. American Journal of Pathology 2004, 164:1511-1518.
91. Sjöblom B., Salmazo A., Djinović-Carugo K. Alpha-actinin structure and regulation. Cellular and Molecular Life Sciences 2008, 65:2688-2701.
92. Smith C.L., Nawaz Z., O'Malley B.W. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Molecular Endocrinology 1997, 11:657-666.
93. Sprague C.R., Fraley T.S., Jang H.S., Lal S., Greenwood J.A. Phosphoinositide binding to the substrate regulates susceptibility to proteolysis by calpain. Journal of Biological Chemistry 2008, 283:9217-9223.
94. Squire J.M. Architecture and function in the muscle sarcomere. Current Opinion in Structural Biology 1997, 7:247-257.
95. Staal S.P., Hartley J.W., Rowe W.P. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proceedings of the National Academy of Sciences of the United States of America 1977, 74:3065-3067.
96. Stål O., Pérez-Tenorio G., Akerberg L., Olsson B., Nordenskjöld B., Skoog L., et al. Akt kinases in breast cancer and the results of adjuvant therapy. Breast Cancer Research 2003, 5:R37-R44.
97. Stanya K.J., Liu Y., Means A.R., Kao H.-Y. Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT. The Journal of Cell Biology 2008, 183:49-61.
98. Su Q., Hu S., Gao H., Ma R., Yang Q., Pan Z., et al. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells. Oncology 2008, 75:159-168.
99. Tang J., Taylor D.W., Taylor K.A. The three-dimensional structure of alpha-actinin obtained by cryoelectron microscopy suggests a model for Ca(2+)-dependent actin binding. Journal of Molecular Biology 2001, 310:845-858.
100. Trulsson M., Yu H., Gisselsson L., Chao Y., Urbano A., Aits S., et al. HAMLET binding to α-actinin facilitates tumor cell detachment. PLoS One 2011, 6:e17179.
101. Vandermoere F., Yazidi-Belkoura I.E., Demont Y., Slomianny C., Antol J., Lemoine J., et al. Proteomics exploration reveals that actin is a signaling target of the kinase Akt. Molecular & Cellular Proteomics 2007, 6:114-124.
102. Wei S., Gao X., Du J., Su J., Xu Z. Angiogenin enhances cell migration by regulating stress fiber assembly and focal adhesion dynamics. PLoS One 2011, 6:e28797.
103. Welsch T., Keleg S., Bergmann F., Bauer S., Hinz U., Schmidt J. Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma. Pancreas 2009, 38:968-976.
104. Yamada S., Yanamoto S., Yoshida H., Yoshitomi I., Kawasaki G., Mizuno A., et al. RNAi-mediated down-regulation of α-actinin-4 decreases invasion potential in oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery 2010, 39:61-67.
105. Yamamoto S., Tsuda H., Honda K., Kita T., Takano M., Tamai S., et al. Actinin-4 expression in ovarian cancer: A novel prognostic indicator independent of clinical stage and histological type. Modern Pathology 2007, 20:1278-1285.
106. Yamamoto S., Tsuda H., Honda K., Onozato K., Takano M., Tamai S., et al. Actinin-4 gene amplification in ovarian cancer: A candidate oncogene associated with poor patient prognosis and tumor chemoresistance. Modern Pathology 2009, 22:499-507.
107. Ylänne J., Scheffzek K., Young P., Saraste M. Crystal structure of the alpha-actinin rod reveals an extensive torsional twist. Structure 2001, 9:597-604.
108. Zhou Y. The NFκB pathway and endocrine-resistant breast cancer. Endocrine-Related Cancer 2005, 12:S37-S46.
109. Zhou C., Zhong Q., Rhodes L.V., Townley I., Bratton M.R., Zhang Q., et al. Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration. Breast Cancer Research 2012, 14:R45.